石四药集团(02005)10月8日斥资572.66万港元回购200万股

Core Viewpoint - The company, Stone Four Pharmaceutical Group, announced a share buyback plan, indicating confidence in its financial position and future prospects [1] Group 1 - The company will spend HKD 5.7266 million to repurchase 2 million shares [1]